Search Results 1871-1880 of 17224 for Hepatocyte
About this study. The purpose of this study is to determine the incidence of rPSC in LT recipients treated with fenofibrate, compared with an untreated ...
Mayo Clinic Uncovers a Crucial Tumor Suppression Function of p53, the Most Commonly Mutated Gene in Human Cancers. Robert Nellis. April 24, 2014. Minnesota.
Study finds little increased risk of injury in high-intensity functional training program. Jay Furst. December 5, 2019. MayoClinicRadio podcast: 11/30/19 ...
The purpose of this study is to determine the feasibility and benefit of a patient-reported outcomes quality of life tool for hematology and medical oncology.
Stem cells may offer new hope for end-stage kidney disease treatment featured image · Mayo Clinic's AI tools help predict severe asthma risks in young children ...
ROCHESTER, Minn. — Mayo Clinic researchers have developed a promising gene-editing therapy that directly corrects a genetic mutation responsible for ...
Early detection improves treatment outcomes for endometrial and ovarian cancers, yet far too often women are diagnosed in advanced stages of these diseases.
Learn about innovative treatment for throat cancers, mouth cancers, tongue cancers, tonsil cancers and other cancers that affect the head and neck.
ROCHESTER, Minn. — A study published in Brain Communications highlights a new approach to treating drug-resistant epilepsy. Researchers at Mayo Clinic have ...
We're in the midst of a microbiome research epidemic, according to Purna Kashyap, M.B.B.S., co-associate director of the Microbiome Program in the Mayo Clinic ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!